The challenge of Messi, Neymar, Suarez and co. may have proved too strong for Mathieu Flamini this week in Arsenals defeat to Barcelona, but February isnt proving all bad for the French midfielder with the unlikely bio-tech businessmans company GFBiochemicals making a bold move into the US market. The Italian-Dutch company is the worlds largest producer of levulinic acid, a platform chemical with significant potential, at commercial scale and in acquiring the assets and intellectual properties of Segetis, the main levulinic acid derivatives producer in the US market it marks a major step forward. The acquisition allows GFBiochemicals to become a producer of a wide range of bio-based products using levulinic acid and is part of the companys strategic plan to establish a direct presence in USA as GFBiochemicals Americas.
By acquiring Segetis, GFBiochemicals gains their expertise, including over 250 patents applications worldwide and their production plant based in Minnesota (USA). Founded in 2008, by the Arsenal FC and former AC Milan and France midfielder Mathieu Flamini (@)alongside business partner Pasquale Granata, the involvement of the soccer star was kept secret until 2015.
The company has a unique set of proprietary technologies that allow levulinic acid and formic acid production with a one-step process directly from a wide range of cellulosic feedstock.
Levulinic acid is a platform chemical with significant potential to replace petroleum-based products in the chemical and biofuel sectors plus plastics and food preservatives. Segetis has been using its chemicals in plastics, perfumes and detergents.
Marcel van Berkel, Chief Commercial Officer of GFBiochemicals (@), commented: Levulinic acid is one of the worlds most versatile building blocks for substituting oil-based products. With the acquisition of the Segetis assets and IP, including the Javelin brand of levulinic ketals technology, we can accelerate market entry for levulinic acid and its derivatives. Segetis is a premium levulinic acid derivatives producer with several proprietary applications including fragrances, plasticizers for PVC & biopolymers, personal care, household & industrial cleaners, agrochemicals formulations and coating / adhesive strippers industries coming from years of research and market development.
Marcel van Berkel, Chief Commercial Officer of GFBiochemicals, continued This acquisition marks an important transformational moment for GFBiochemicals and the beginning of growth strategy. The Company will continue on a development path based on both organic growth via the creation of high-value partnerships with major companies, as well as the potential for further acquisitions of levulinic acids derivative technologies.
GFBiochemicals has an international presence employing more than 50 people with headquarters in Milan, Italy, R&D and commercial office in Geleen, The Netherlands and production sites in: Caserta, Italy and Minnesota, USA.
Interested in this development for bio-based products from bio-based chemicals this then you might also like …